Full history for every metric is available with a Kvantra account
Key financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 920 | 1,106 | 1,199 | 1,359 | 1,511 | 1,580 | 1,576 | 1,642 |
| Operating profit | £m | 146 | 118 | ||||||
| Net profit | £m | -234 | -10 | 9 | 27 | 25 | 16 | -2 | 45 |
| EPS reported | £ | 0.04 | -0.00 | ||||||
| Operating cashflow per share | £ | 0.55 | 0.54 | ||||||
| Capex per share | £ | 0.19 | 0.15 | ||||||
| FCF per share | £ | 0.36 | 0.39 | ||||||
| Free cash flow | £m | 143 | 156 | ||||||
| Net debt | £m | 440 | 1,277 | ||||||
| Book value equity | £m | 743 | 726 | ||||||
| Book value per share | £ | 1.83 | 1.81 | ||||||
| Number of shares | m | 405.31 | 401.01 | ||||||
| DPS (TTM paid) | £ | 0.02 | 0.02 |
Financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 41.23 | - | ||||||
| P/B LTM | x | 0.90 | 1.36 | ||||||
| P/S LTM | x | 0.42 | 0.63 | ||||||
| P/FCF LTM | x | 4.68 | 6.34 | ||||||
| EV/EBITDA LTM | x | 7.34 | 9.40 | ||||||
| EV/Sales LTM | x | 1.23 | 1.44 | ||||||
| Earnings Yield LTM | % | 2.43% | -0.19% | ||||||
| FCF Yield | % | 21.39% | 15.77% | ||||||
| Quality | |||||||||
| ROE | % | 2.21% | -0.26% | ||||||
| ROIC | % | 6.31% | 1.03% | ||||||
| Operating margin | % | 9.25% | 7.46% | ||||||
| Gross margin | % | 37.92% | 37.53% | ||||||
| FCF/Sales | % | 9.05% | 9.90% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -34.36% | - | ||||||
| Sales Growth YoY | % | +4.54% | +1.97% | ||||||
| Net Income Growth YoY | % | -35.43% | - | ||||||
| FCF Growth | % | +15.70% | +17.38% | ||||||
| Operating Profit Growth | % | +6.25% | -8.84% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 1.38% | 0.61% | ||||||
| Dividend Growth | % | -34.78% | -34.78% | ||||||
| Payout Ratio | % | 56.05% | 56.10% | ||||||
| FCF/Debt | x | 0.11 | 0.12 | ||||||
| Net Debt/EBITDA | x | 4.82 | 5.30 | ||||||
| EBIT/Net interest | x | 1.39 | 1.11 | ||||||
| Net debt/market cap | % | 65.81% | 129.09% | ||||||
| Net debt/Equity | x | 0.59 | 1.76 | ||||||
| Gross debt/equity | x | 1.77 | 1.80 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Spire Healthcare Group plc (SPI.L)
Based on consensus from external analysts. Not Kvantra's opinion.
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free